Narrow search
Showing 1 - 10 of 62,063
Cover Image
Pharmaceutical regulation in Europe and its impact on corporate R&D
Eger, Stephan; Mahlich, Jörg C. - In: Health economics review 4 (2014) 23, pp. 1-9
expenditures. On the other hand, regulation distorts incentives to invest in pharmaceutical R&D. This study aims at empirically … assessing the impact of regulation on pharmaceutical R&D expenditures. Methods: We analyze a sample of 20 leading pharmaceutical … companies between 2000 and 2008. The share of sales in Europe serves as a proxy for the degree of pharmaceutical regulation. We …
Persistent link: https://www.econbiz.de/10010526909
Cover Image
Pharmaceutical regulation in Europe and its impact on corporate R&D
Eger, Stephan; Mahlich, Jörg - In: Health Economics Review 4 (2014) 1, pp. 1-9
The results can be interpreted as further evidence of the deteriorating effect of regulation on firm’s incentives to …
Persistent link: https://www.econbiz.de/10010998792
Cover Image
R&D and financial systems: the determinants of R&Dexpenditures in the Swedish pharmaceutical industry
Malmberg, Claes - Centre for Innovation, Research and Competence in the … - 2008
This study investigates the determinants of R&D expenditures in the Swedish pharmaceutical industry from the 1960s to the mid 1990s. Various proxies for the rate of return of R&D (e.g. expected profit, sales and R&D productivity) as well as the availability of internal funding (proxied by past...
Persistent link: https://www.econbiz.de/10008764489
Cover Image
R&D and financial systems: the determinants of R&D expenditures in the Swedish pharmaceutical industry
Malmberg, Claes - Centre for Innovation, Research and Competence in the … - 2008
This study investigates the determinants of R&D expenditures in the Swedish pharmaceutical industry from the 1960s to the mid 1990s. Various proxies for the rate of return of R&D (e.g. expected profit, sales and R&D productivity) as well as the availability of internal funding (proxied by past...
Persistent link: https://www.econbiz.de/10005077278
Cover Image
Board characteristics, financial slack and R&D investments : an empirical analysis of the Indian pharmaceutical industry
Ashwin, A. S.; Krishnan, Rishikesha T.; George, Rejie - In: International studies of management and organization 46 (2016) 1, pp. 8-23
Persistent link: https://www.econbiz.de/10011450101
Cover Image
Find and replace : R&D investment following the erosion of existing products
Krieger, Joshua; Li, Xuelin - 2018
Persistent link: https://www.econbiz.de/10012019907
Cover Image
Find and replace : R&D investment following the erosion of existing products
Krieger, Joshua L.; Li, Xuelin; Thakor, Richard T. - In: Management science : journal of the Institute for … 68 (2022) 9, pp. 6552-6571
Persistent link: https://www.econbiz.de/10013373030
Cover Image
The impact of relaxing technology export regulations on corporate innovation
Li, Haoyang; Yang, Mingjing; Sun, Yanqi; Chen, Jingwei - In: Finance research letters 50 (2022), pp. 1-9
Persistent link: https://www.econbiz.de/10014240171
Cover Image
Disentangling corporate social responsibility: the impact of corporate governance on the social and environmental performance of pharmaceutical and biotech firms
Gangi, Francesco; D'Angelo, Eugenio; Daniele, Lucia Michela - In: Handbook of research methods for corporate governance : …, (pp. 160-198). 2023
Persistent link: https://www.econbiz.de/10014330617
Cover Image
Drug problem or medicrime? : distribution and use of falsified Tramadol medication in Egypt and West Africa
Klein, Axel - In: Journal of illicit economies and development : JIED 1 (2019) 1, pp. 52-62
patient well-being. A further shift is needed away from repressive measures against consumers, to tighter regulation in the …
Persistent link: https://www.econbiz.de/10012260588